UTAH MEDICAL PRODUCTS INC - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - November 7, 2011



Attached files
FileFilename
EXCEL - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCFinancial_Report.xls
10-Q - UTAH MEDICAL PRODUCTS, INC. 10Q 2011-09-30 - UTAH MEDICAL PRODUCTS INCutahmedical10q20110930.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR4.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR6.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR7.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR9.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR8.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR5.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR1.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR2.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR14.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR13.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR11.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR12.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR10.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - UTAH MEDICAL PRODUCTS INCutahmedical10qexh322.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - UTAH MEDICAL PRODUCTS INCutahmedical10qexh311.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - UTAH MEDICAL PRODUCTS INCutahmedical10qexh312.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - UTAH MEDICAL PRODUCTS INCutahmedical10qexh321.htm
v2.3.0.15
UTAH MEDICAL PRODUCTS, INC. AND SUBSIDIARIES CONSOLIDATED CONDENSED STATEMENTS OF INCOME (USD $)
In Thousands, except Per Share data
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Sales, net$ 10,784$ 6,201$ 27,954$ 18,912
Cost of goods sold4,2662,86511,4668,987
Gross profit6,5183,33616,4879,925
Selling, general and administrative2,8429777,1722,893
Research and development138101386292
Total Operating Expense2,9791,0787,5583,184
Operating income3,5392,2578,9296,741
Other income (expense)(265)31(561)66
Income before provision for income taxes3,2742,2898,3686,807
Provision for income taxes1,0377772,8122,302
Net income$ 2,237$ 1,512$ 5,556$ 4,505
Earnings per common shares (basic)$ 0.62$ 0.42$ 1.53$ 1.24
Earnings per common share (diluted)$ 0.61$ 0.42$ 1.53$ 1.24
Shares outstanding - basic3,6363,6163,6293,622
Shares outstanding - diluted3,6443,6313,6423,643

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA



This web site and associated pages are not associated with, endorsed by, or sponsored by UTAH MEDICAL PRODUCTS INC and has no official or unofficial affiliation with UTAH MEDICAL PRODUCTS INC


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.